学术探索
学术期刊
新闻热点
数据分析
智能评审

The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases

被引：44
作者：
Pyne, D [1 ]
Ehrenstein, M [1 ]
Morris, V [1 ]
机构：
[1] UCL, Ctr Rheumatol, London W1P 9PJ, England
来源：
RHEUMATOLOGY | 2002年 / 41卷 / 04期
关键词：
D O I：
10.1093/rheumatology/41.4.367
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：367 / 374
页数：8
相关论文
共 79 条
[41]   Successful treatment of adult-onset Henoch-Schonlein purpura nephritis with high-dose immunoglobulins [J].
Kusuda, A ;
Migita, K ;
Tsuboi, M ;
Degawa, M ;
Matsuoka, N ;
Tominaga, M ;
Kawakami, A ;
Kawabe, Y ;
Taguchi, T ;
Eguchi, K .
INTERNAL MEDICINE, 1999, 38 (04) :376-379
[42]   TREATMENT OF DERMATOMYOSITIS WITH INTRAVENOUS GAMMA-GLOBULIN [J].
LANG, BA ;
LAXER, RM ;
MURPHY, G ;
SILVERMAN, ED ;
ROIFMAN, CM .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (02) :169-172
[43]   Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins [J].
Levy, Y ;
George, J ;
Fabbrizzi, F ;
Rotman, P ;
Paz, Y ;
Shoenfeld, Y .
SOUTHERN MEDICAL JOURNAL, 1999, 92 (04) :412-414
[44]   Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin [J].
Levy, Y ;
Sherer, Y ;
George, J ;
Langevitz, P ;
Ahmed, A ;
Bar-Dayan, Y ;
Fabbrizzi, F ;
Terryberry, J ;
Peter, J ;
Shoenfeld, Y .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 119 (03) :231-238
[45]   Intravenous immunoglobulin treatment of lupus nephritis [J].
Levy, Y ;
Sherer, Y ;
George, J ;
Rovensky, J ;
Lukac, J ;
Rauova, L ;
Poprac, P ;
Langevitz, P ;
Fabbrizzi, F ;
Shoenfeld, Y .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2000, 29 (05) :321-327
[46]   IMPROVEMENT OF HISTOLOGICAL AND IMMUNOLOGICAL CHANGE IN STEROID AND IMMUNOSUPPRESSIVE DRUG-RESISTANT LUPUS NEPHRITIS BY HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN [J].
LIN, CY ;
HSU, HC ;
CHIANG, H .
NEPHRON, 1989, 53 (04) :303-310
[47]  
MAIER WP, 1990, ARTHRITIS RHEUM, V33, P1233
[48]   ADVERSE-EFFECTS OF INTRAVENOUS IMMUNOGLOBULIN [J].
MISBAH, SA ;
CHAPEL, HM .
DRUG SAFETY, 1993, 9 (04) :254-262
[49]  
*MMWR, 1994, MORBIDITY MORTALITY, V43, P505
[50]   Mechanisms of action of intravenous immune globulin in immune-mediated diseases [J].
Mouthon, L ;
Kaveri, SV ;
Spalter, SH ;
LacroixDesmazes, S ;
Lefranc, C ;
Desai, R ;
Kazatchkine, MD .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 :3-9
12345678